Research Article| Volume 60, ISSUE 10, P1475-1481, October 2011

Vitamin D deficiency is common and associated with metabolic risk factors in patients with polycystic ovary syndrome


      Both vitamin D deficiency and polycystic ovary syndrome (PCOS) are associated with aspects of metabolic syndrome, but it is unclear whether vitamin D deficiency contributes to the metabolic disturbances commonly found in women with PCOS. This study sought to investigate (1) the prevalence of vitamin D deficiency in PCOS women in Scotland and (2) the relationship between vitamin D status and metabolic risk factors. This was an observational study on 52 women (25 in PCOS group and 27 in control group). Serum 25-hydroxyvitamin D concentrations less than 25 nmol/L were classified as severe vitamin D deficiency and were found in 44.0% and 11.2% of subjects in the PCOS and control groups, respectively (P = .047). Among the PCOS subjects, 25-hydroxyvitamin D concentrations were negatively correlated with body mass index (P = .033), C-reactive protein (P = .027), and free androgen index (P = .025) and positively correlated with quantitative insulin sensitivity check index (P = .035), high-density lipoprotein cholesterol (HDL-C) (P = .033), and sex hormone binding globulin (P = .038). Associations of vitamin D deficiency with quantitative insulin sensitivity check index and HDL-C were independent of body mass index and waist-to-hip ratio. Vitamin D deficiency is highly prevalent in PCOS women in Scotland, and a larger proportion of PCOS patients than control women were found to be vitamin D deficient. We also demonstrate correlations of vitamin D status with insulin sensitivity, HDL-C, and C-reactive protein in PCOS patients, which support the increasing evidence that vitamin D deficiency is associated with multiple metabolic risk factors in PCOS women.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Metabolism - Clinical and Experimental
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Holick M.F.
        Vitamin D: importance in the prevention of cancers, type 1 diabetes, heart disease, and osteoporosis.
        Am J Clin Nutr. 2004; 79: 362-371
        • Holick M.F.
        Vitamin D deficiency.
        N Engl J Med. 2007; 357: 266-281
        • Harkness L.
        • Cromer B.
        Low levels of 25-hydroxy vitamin D are associated with elevated parathyroid hormone in healthy adolescent females.
        Osteoporos Int. 2005; 16: 109-113
        • Dawson-Hughes B.
        • Heaney R.P.
        • Holick M.F.
        • et al.
        Estimates of optimal vitamin D status.
        Osteoporos Int. 2005; 16: 713-716
        • Hypponen E.
        • Power C.
        Hypovitaminosis D in British adults at age 45 y: nationwide cohort study of dietary and lifestyle predictors.
        Am J Clin Nutr. 2007; 85: 860-868
        • Norman R.J.
        • Dewailly D.
        • Legro R.S.
        • et al.
        Polycystic ovary syndrome.
        Lancet. 2007; 370: 685-697
        • Thys-Jacobs S.
        • Donovan D.
        • Papadopoulos A.
        • et al.
        Vitamin D and calcium dysregulation in the polycystic ovarian syndrome.
        Steroids. 1999; 64: 430-435
        • Wehr E.
        • Pilz S.
        • Schweighofer N.
        • et al.
        Association of hypovitaminosis D with metabolic disturbances in polycystic ovary syndrome.
        Eur J Endocrinol. 2009; 161: 575-582
        • Hahn S.
        • Haselhorst U.
        • Tan S.
        • et al.
        Low serum 25-hydroxyvitamin D concentrations are associated with insulin resistance and obesity in women with polycystic ovary syndrome.
        Exp Clin Endocrinol Diabetes. 2006; 114: 577-583
        • Yildizhan R.
        • Kurdoglu M.
        • Adali E.
        • et al.
        Serum 25-hydroxyvitamin D concentrations in obese and non-obese women with polycystic ovary syndrome.
        Arch Gynecol Obstet. 2009; 280: 559-563
        • Michos E.D.
        • Melamed M.L.
        Vitamin D and cardiovascular disease risk.
        Curr Opin Clin Nutr Metab Care. 2008; 11: 7-12
        • Rotterdam ESHRE/ASRM-Sponsored PCOS consensus workshop group
        Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS).
        Hum Reprod. 2004; 19: 41-47
        • Knox S.
        • Harris J.
        • Calton L.
        • et al.
        A simple automated solid-phase extraction procedure for measurement of 25-hydroxyvitamin D3 and D2 by liquid chromatography-tandem mass spectrometry.
        Ann Clin Biochem. 2009; 46: 226-230
        • Carter G.D.
        • Holland S.M.
        • Alaghband-Zadeh J.
        • et al.
        Investigation of hirsutism: testosterone is not enough.
        Ann Clin Biochem. 1983; 20: 262-263
        • Matthews D.R.
        • Hosker J.P.
        • Rudenski A.S.
        • et al.
        Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man.
        Diabetologia. 1985; 28: 412-419
        • Katz A.
        • Nambi S.S.
        • Mather K.
        • et al.
        Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans.
        J Clin Endocrinol Metab. 2000; 85: 2402-2410
        • Ruston D.
        • Hoare J.
        • Henderson L.
        • et al.
        The National Diet & Nutrition Survey: adults aged 19 to 64 years: nutritional status (anthropometry and blood analytes), blood pressure and physical activity. The Stationery Office, London2004: 54-56
        • Lagunova Z.
        • Porojnicu A.C.
        • Lindberg F.
        • et al.
        The dependency of vitamin D status on body mass index, gender, age and season.
        Anticancer Res. 2009; 29: 3713-3720
        • Moran L.
        • Teede H.
        Metabolic features of the reproductive phenotypes of polycystic ovary syndrome.
        Hum Reprod Update. 2009; 15: 477-488
        • Teegarden D.
        • Donkin S.S.
        Vitamin D: emerging new roles in insulin sensitivity.
        Nutr Res Rev. 2009; 22: 82-92
        • Kayaniyil S.
        • Vieth R.
        • Harris S.B.
        • et al.
        Association of 25(OH)D and PTH with metabolic syndrome and its traditional and nontraditional components.
        J Clin Endocrinol Metab. 2011; 96: 168-175
        • Pittas A.G.
        • Lau J.
        • Hu F.B.
        • et al.
        The role of vitamin D and calcium in type 2 diabetes. A systematic review and meta-analysis.
        J Clin Endocrinol Metab. 2007; 92: 2017-2029
        • Kotsa K.
        • Yavropoulou M.P.
        • Anastasiou O.
        • Yovos J.G.
        Role of vitamin D treatment in glucose metabolism in polycystic ovary syndrome.
        Fertil Steril. 2009; 92: 1053-1058
        • Selimoglu H.
        • Duran C.
        • Kiyici S.
        • et al.
        The effect of vitamin D replacement therapy on insulin resistance and androgen levels in women with polycystic ovary syndrome.
        J Endocrinol Invest. 2010; 33: 234-238